embody vs altRx vs welludr: Best Budget GLP-1 Providers
Last updated: Sep 1, 2026
Reviewed for medical accuracy by Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Clinically checked Checked · Author: Top Weight Loss Research Team · Our review process
Some links on this page earn us a commission, which has no effect on how providers rank (our editorial independence).
Quick answer
welludr, embody and altRx are the budget options for compounded GLP-1 medication, and each reaches a low price in a different way. welludr's $49/month requires a 12-month plan. embody's $69/month is flat with no commitment at all. altRx's $89/month comes with the option to move to brand-name Ozempic or Zepbound later. The active ingredients are the same at all three, so the table below really compares commitment, delivery and future options.
Semaglutide from $69/mo, delivered in 1-2 days
Go to embody
Compounded semaglutide from $49/month and tirzepatide from $89/month
Go to welludrHow do embody, altRx, welludr compare?
Published prices and plan terms for all three providers, row by row, so the real differences are easy to spot.
| embody | altRx | welludr | |
|---|---|---|---|
| Semaglutide price | $69/mo at every dose | $89/mo at every dose (reg. $199) | $49/mo on a 12-month plan, any dose |
| Tirzepatide price | $119/mo | $149/mo (reg. $299) | $89/mo |
| Billing & contract | Month-to-month, cancel whenever you like | Monthly with pause or cancel anytime; Buy Now, Pay Later | Billed monthly; lowest rate needs a 12-month plan |
| Delivery | Free in 1-2 days, tracked and insured | Free nationwide delivery | Free, discreet refills every 4 weeks |
| Care & support | Licensed doctors plus a medical director and nurses | Reviewed by a licensed physician, PA or NP | A Medical Weight-Care Coach on every plan |
| Refund or guarantee | 100% refund if a provider declines you | - | Weight-loss warranty (see site for terms) |
| Stands out for | LegitScript certification; 503A pharmacy network | Brand-name options: Ozempic $1,149 · Zepbound $1,249 · Wegovy $1,579 | Board-certified specialists; 1M+ patients served |
Which one we recommend
Let your appetite for commitment decide. If you are ready to commit for a year and price is what matters most, welludr's $49 can't be beaten. If you want to be able to stop at any time, embody is the cleanest deal on the market: $69 flat, 1-2 day shipping and a refund if you aren't approved. If brand-name medication might be in your future, altRx is the only one of the three with a brand shelf, and Buy Now, Pay Later spreads the cost. None of these is a legitimacy risk; all three rely on licensed-provider review and regulated pharmacies.
embody vs altRx vs welludr: common questions
Is embody, altRx or welludr the cheapest?
welludr has the lowest headline price for compounded semaglutide at $49/month, but only on a 12-month plan. embody charges $69/month flat with no commitment, and altRx charges $89/month with pause-anytime terms and Buy Now, Pay Later. For tirzepatide, welludr is $89, embody $119 and altRx $149.
Do embody, altRx and welludr all require a prescription?
Yes. At all three telehealth providers, a licensed clinician reviews your medical intake and decides whether GLP-1 treatment is appropriate, so approval is never automatic. Licensed pharmacies dispense the medication.
Which provider delivers fastest?
embody is fastest, shipping free in 1-2 days with tracking and insurance. altRx offers free nationwide delivery on standard timelines. welludr ships free every 4 weeks in discreet packaging timed to its dosing cycle.
Compare them in pairs
One-on-one matchups between each pair of these three providers.
References and clinical sources
The medication facts on this page rest on FDA guidance and peer-reviewed clinical trials, while prices and plan terms come from what each provider publishes. Use this page as general information, not medical advice, and speak with a licensed clinician before you start any weight loss treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)